Those with versus without a prior MI and stroke were more likely to be white; have HF; be taking β-blockers, mineralocorticoid receptor antagonists, statins, or clopidogrel; and less likely to have a diagnosis of T2DM for >10 years. Here, NR3C2 is linked to stroke disorder.